Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gérard Helft

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Journal of Thoracic Disease|September 14, 2016
Dual antiplatelet therapy duration after drug-eluting stents: how long?Gérard Helft
Archives of Cardiovascular Diseases|June 18, 2013
Optimal duration of dual antiplatelet therapy after drug-eluting stent implantationGérard Helft
Journal of Thoracic Disease|November 22, 2016
New guidelines on duration of dual antiplatelet therapy in patients with coronary artery disease: what's the novelty?Gérard Helft
Evidence-Based Medicine|March 7, 2015
Prolonged dual antiplatelet therapy after drug-eluting stent reduces the risk of stent thrombosis and major cardiovascular events but increases the rate of bleedingGérard Helft
Presse Medicale (Paris, France : 1983)|November 3, 2009
[Long-term use of oral antiplatelet therapy: from studies to practice]Gérard Helft
Archives of Cardiovascular Diseases|October 4, 2015
The saga of the duration of dual antiplatelet therapy after drug-eluting stent placementGérard Helft
Presse Medicale (Paris, France : 1983)|April 29, 2008
[Self-monitoring of oral coagulation: for which patients?]Gérard Helft, Jacques Blacher
JACC. Cardiovascular Interventions|February 24, 2015
The arranged marriage of cangrelor and bivalirudinGilles Montalescot, Gérard Helft
The New England Journal of Medicine|December 14, 2012
Fractional flow reserve-guided PCI in stable coronary diseaseGérard Helft, Rémi Choussat, Azfar Zaman
Cardiovascular Psychiatry and Neurology|January 24, 2014
Effects of age and cardiovascular disease on selective attentionSylvie Chokron, Gérard Helft, Céline Perez
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Journal of Thoracic Disease|September 14, 2016
Dual antiplatelet therapy duration after drug-eluting stents: how long?Gérard Helft
Archives of Cardiovascular Diseases|June 18, 2013
Optimal duration of dual antiplatelet therapy after drug-eluting stent implantationGérard Helft
Journal of Thoracic Disease|November 22, 2016
New guidelines on duration of dual antiplatelet therapy in patients with coronary artery disease: what's the novelty?Gérard Helft
Evidence-Based Medicine|March 7, 2015
Prolonged dual antiplatelet therapy after drug-eluting stent reduces the risk of stent thrombosis and major cardiovascular events but increases the rate of bleedingGérard Helft
Presse Medicale (Paris, France : 1983)|November 3, 2009
[Long-term use of oral antiplatelet therapy: from studies to practice]Gérard Helft
Archives of Cardiovascular Diseases|October 4, 2015
The saga of the duration of dual antiplatelet therapy after drug-eluting stent placementGérard Helft
Presse Medicale (Paris, France : 1983)|April 29, 2008
[Self-monitoring of oral coagulation: for which patients?]Gérard Helft, Jacques Blacher
JACC. Cardiovascular Interventions|February 24, 2015
The arranged marriage of cangrelor and bivalirudinGilles Montalescot, Gérard Helft
The New England Journal of Medicine|December 14, 2012
Fractional flow reserve-guided PCI in stable coronary diseaseGérard Helft, Rémi Choussat, Azfar Zaman
Cardiovascular Psychiatry and Neurology|January 24, 2014
Effects of age and cardiovascular disease on selective attentionSylvie Chokron, Gérard Helft, Céline Perez
Pageof 6